{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:51:23Z","timestamp":1761857483278,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.pathol.2021.06.116","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T08:48:04Z","timestamp":1629362884000},"page":"700-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-4185","authenticated-orcid":false,"given":"Edward H.","family":"Tsoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-5609","authenticated-orcid":false,"given":"Richard A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Christie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Machet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Deb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina R.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.F.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.06.116_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MCG.0000000000001027","article-title":"Barrett esophagus length, nodularity, and low-grade dysplasia are predictive of progression to esophageal adenocarcinoma","volume":"53","author":"Solanky","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0042-122140","article-title":"Endoscopic management of Barrett\u2019s esophagus: European society of gastrointestinal endoscopy (ESGE) position statement","volume":"49","author":"Weusten","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.pathol.2021.06.116_bib3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","article-title":"Radiofrequency ablation in Barrett's esophagus with dysplasia","volume":"360","author":"Shaheen","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.06.116_bib4","doi-asserted-by":"crossref","first-page":"E849","DOI":"10.1055\/s-0042-109608","article-title":"Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett\u2019s esophagus may not be benign","volume":"4","author":"Cameron","year":"2016","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.pathol.2021.06.116_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gie.2016.12.001","article-title":"The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial)","volume":"86","author":"Phoa","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pathol.2021.06.116_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","article-title":"Durability of radiofrequency ablation in Barrett's esophagus with dysplasia","volume":"141","author":"Shaheen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.06.116_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/gutjnl-2015-309298","article-title":"Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)","volume":"65","author":"Phoa","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2021.06.116_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2014.2511","article-title":"Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial","volume":"311","author":"Phoa","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2021.06.116_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5694\/mja16.00796","article-title":"Barrett's oesophagus: epidemiology, diagnosis and clinical management","volume":"205","author":"Whiteman","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2021.06.116_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2011.06.055","article-title":"Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus","volume":"141","author":"Wani","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.06.116_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","article-title":"Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated","volume":"105","author":"Curvers","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/gutjnl-2014-307278","article-title":"Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel","volume":"64","author":"Duits","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2021.06.116_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2007-966592","article-title":"Low-grade dysplasia in Barrett's esophagus has a high risk of progression","volume":"39","author":"Lim","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.pathol.2021.06.116_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cgh.2015.12.027","article-title":"Patients with Barrett\u2019s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer","volume":"14","author":"Kestens","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pathol.2021.06.116_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1572-0241.2007.01073.x","article-title":"Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus","volume":"102","author":"Srivastava","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.gastro.2016.12.008","article-title":"Patients with Barrett\u2019s esophagus and confirmed persistent low-grade dysplasia are at increased risk for progression to neoplasia","volume":"152","author":"Duits","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.06.116_bib17","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","article-title":"Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib18","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1208598","article-title":"Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk","volume":"24","author":"Schulmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2021.06.116_bib19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.12.009","article-title":"Development and validation of a model to determine risk of progression of Barrett's esophagus to neoplasia","volume":"154","author":"Parasa","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.06.116_bib20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1572-0241.2001.03844.x","article-title":"p53 and neoplastic progression in Barrett's esophagus","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib21","doi-asserted-by":"crossref","first-page":"S-898","DOI":"10.1016\/S0016-5085(18)33029-4","article-title":"Tu1122 - early histological predictors of progression in patients with Barrett's esophagus related low grade dysplasia","volume":"154","author":"Tsoi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.06.116_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/PAS.0000000000001066","article-title":"Improved progression prediction in Barrett\u2019s esophagus with low-grade dysplasia using specific histologic criteria","volume":"42","author":"Ten Kate","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.06.116_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","article-title":"Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2021.06.116_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jcp.2005.035337","article-title":"Diagnosis and grading of dysplasia in Barrett\u2019s oesophagus","volume":"59","author":"Odze","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.06.116_bib25","first-page":"586","article-title":"Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study","volume":"92","author":"Cameron","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.06.116_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus","volume":"19","author":"Reid","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2021.06.116_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.47.2.251","article-title":"The Vienna classification of gastrointestinal epithelial neoplasia","volume":"47","author":"Schlemper","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2021.06.116_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0016-5085(84)90588-2","article-title":"Esophageal dysplasia. Assessment by light microscopy and scanning electron microscopy","volume":"86","author":"Goran","year":"1984","journal-title":"Gastroenterology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:27:18Z","timestamp":1758472038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521004219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0031302521004219"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.06.116","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.06.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}